InfuSystem Holdings (INFU) Gross Profit Growth (3y) (2013 - 2026)

InfuSystem Holdings (INFU) Gross Profit Growth (3y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (3y) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 5.02%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 8.10%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 4.54%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 15.44%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 9.03%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.15%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 17.49%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 1.49%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 8.46%
10 InfuSystem Holdings 189.78 Mn 187.68 Mn 19.68 Mn 9.60%

Historic Data

Download Data
DateValue
Mar 31, 2026 9.60%
Dec 31, 2025 13.24%
Sep 30, 2025 8.68%
Jun 30, 2025 10.08%
Mar 31, 2025 7.64%
Dec 31, 2024 10.09%
Sep 30, 2024 7.67%
Jun 30, 2024 3.46%
Mar 31, 2024 4.16%
Dec 31, 2023 3.68%
Sep 30, 2023 1.08%
Jun 30, 2023 -0.31%
Mar 31, 2023 5.69%
Dec 31, 2022 2.82%
Sep 30, 2022 9.84%
Jun 30, 2022 9.48%
Mar 31, 2022 14.11%
Dec 31, 2021 11.03%
Sep 30, 2021 16.40%
Jun 30, 2021 15.82%